Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (100.0%)Safety and Efficacy of Topical AR/101 Compared With Placebo, in Accelerating Granulation Tissue Formation of Hard-to-heal Wounds
Phase 2
- Conditions
- Other Ulcers Wounds and Skin ProblemsWounds
- Interventions
- Drug: PlaceboDrug: AR/101
- First Posted Date
- 2016-07-20
- Last Posted Date
- 2016-07-20
- Lead Sponsor
- Arava Bio Tech Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT02839226
- Locations
- 🇮🇱
Sourasky Medical Center, Tel Aviv, Israel
Safety and Efficacy of AR/101 in Accelerating Re-epithelialization of Split Thickness Wounds
Phase 2
- Conditions
- Wounds and Injuries
- Interventions
- Drug: AR/101Drug: Placebo
- First Posted Date
- 2015-11-11
- Last Posted Date
- 2016-07-19
- Lead Sponsor
- Arava Bio Tech Ltd.
- Target Recruit Count
- 18
- Registration Number
- NCT02602184
- Locations
- 🇺🇸
Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
News
No news found